Healthcare & Biotech
Perlara
Perlara: building the YC for rare disease parents
Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase…
- Drug Discovery and Delivery
- Website
- perlara.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 1 people
- Founded
- 2016
- Demo
- Demo only
Similar companies
Sequence BioDiscovering the true signals of disease to power life-changing drugs.
Ditto BiosciencesEvolutionary intelligence for autoimmune disease
AdaptyvWe're building fully automated labs for protein engineering
Parallel BioUsing the immune system to cure disease
Avro Life ScienceSkin patches for generic drug delivery.
MiracleAccelerate clinical trials with real-time, actionable insights
Adventris PharmaceuticalsAdventris makes cancer vaccines
Atlas DiscoveryAI-native pharma company